T

he $500,000 Lemelson-MIT Prize is being awarded this year to bioengineer Feng Zhang, a key developer of CRISPR genome-editing technology, the prize jury announced on Tuesday.

Although Zhang, whose lab is at the Broad Institute of MIT and Harvard, is best known for CRISPR advances such as editing genes in human and mouse cells, he wasn’t honored only for that, said bioengineer Michael Cima of MIT’s Koch Institute, the faculty director of the award.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.